KIF20A is a Prognostic Marker for Female Patients with Estrogen Receptor-Positive Breast Cancer and Receiving Tamoxifen as Adjuvant Endocrine Therapy

Xuchen Huang,1,2 Sainan Li,1,2 Wei Gao,1,2 Jiajie Shi,1,2 Meng Cheng,1,2 Yunzhe Mi,1,2 Yueping Liu,3 Meixiang Sang,4 Ziyi Li,4 Cuizhi Geng1,2 1Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China; 2Key Laboratory in Hebei Provi...

Full description

Bibliographic Details

Published in:	International Journal of General Medicine
Main Authors:	Huang X, Li S, Gao W, Shi J, Cheng M, Mi Y, Liu Y, Sang M, Li Z, Geng C
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-08-01
Subjects:	kif20a breast carcinoma biomarker tamoxifen survival prognosis
Online Access:	https://www.dovepress.com/kif20a-is-a-prognostic-marker-for-female-patients-with-estrogen-recept-peer-reviewed-fulltext-article-IJGM